<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Thymosin alpha-1</title><link>https://peptidescanner.com/peptides/thymosin-alpha-1/</link><description>Versioned, source-linked PeptideScanner evidence objects for Thymosin alpha-1. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/thymosin-alpha-1.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00001036</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00001036-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00001036-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2008-07-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00711620</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00711620-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00711620-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-06-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00911443</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00911443-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00911443-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2009-07-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01031966</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01031966-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01031966-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-03-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01178996</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01178996-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01178996-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2010-08-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02473406</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02473406-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02473406-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-04-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02646189</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02646189-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02646189-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-01-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02867267</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02867267-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02867267-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-04-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02883595</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02883595-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02883595-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-04-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03659578</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03659578-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03659578-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-01-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04428008</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04428008-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04428008-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-04-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05086614</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05086614-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05086614-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-10-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06024356</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06024356-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06024356-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-06-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06139419</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06139419-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06139419-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06461910</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06461910-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06461910-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-03-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07780721</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07780721-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07780721-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07884201</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07884201-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07884201-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07922954</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07922954-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07922954-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha-1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-11381492-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-11381492-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-11381492-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-02-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-12860169-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-12860169-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-12860169-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-11-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymalfasin for the treatment of chronic hepatitis B.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15482167-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15482167-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15482167-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15546255-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15546255-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15546255-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15641208-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15641208-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641208-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15641209-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15641209-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641209-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymalfasin for the treatment of chronic hepatitis C infection.</title><link>https://peptidescanner.com/stories/pubmed-pmid-16307501-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16307501-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-16307501-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.</title><link>https://peptidescanner.com/stories/pubmed-pmid-17600281-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-17600281-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-17600281-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-18410608-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18410608-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-18410608-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19033321-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19033321-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19033321-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>From lab to bedside: emerging clinical applications of thymosin alpha 1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19392576-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19392576-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19392576-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19467157-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19467157-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19467157-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-05-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20194853-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20194853-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20194853-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-04-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20536445-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20536445-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536445-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1: past clinical experience and future promise.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20536460-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20536460-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536460-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20536461-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20536461-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536461-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymalfasin in the treatment of hepatitis B and C.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20536462-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20536462-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536462-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].</title><link>https://peptidescanner.com/stories/pubmed-pmid-21272455-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21272455-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-21272455-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22010537-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22010537-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22010537-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?</title><link>https://peptidescanner.com/stories/pubmed-pmid-22233415-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22233415-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22233415-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1 and HIV-1: recent advances and future perspectives.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28106477-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28106477-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-28106477-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30063860-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30063860-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063860-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-01-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Serum thymosin alpha 1 levels in normal and pathological conditions.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30063864-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30063864-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063864-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1 treatment for patients with sepsis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30063866-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30063866-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063866-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin alpha 1: A comprehensive review of the literature.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33362999-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33362999-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-33362999-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-12-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phenotypic drug discovery: a case for thymosin alpha-1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38903817-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38903817-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-38903817-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-06-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39648386-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39648386-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-39648386-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-12-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Aging and Thymosin Alpha-1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41373628-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41373628-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41373628-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-12-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41749205-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41749205-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41749205-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42797537-thymosin-alpha-1/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42797537-thymosin-alpha-1:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-42797537-thymosin-alpha-1-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
